iPLATO Patient Care Messaging Reaches 10 Million Patients in England

iPLATOiPLATO the UK's leader in Health Tech announces today that its flagship GP service, iPLATO Patient Care Messaging now reaches more than 10 million patients through over 1,000 GP practices in England. iPLATO Patient Care Messaging allows practices to set up automated appointment reminders and to run high performance mobile patient engagement using text messaging as its primary communication channel.

A first version launched in 2006 iPLATO Patient Care Messaging has been now been adopted by 1 in 8 of GP practices in England. The rate of adoption has increased rapidly over the past 3 months with and an additional seven Clinical Commissioning Groups from the North West of England to Bexley in the South East are expanding their iPLATO Patient Care Messaging services to cover their entire populations adding 170 GP practices covering some 1.2 million patients to the iPLATO network.

Clinical Commissioning Groups sign up to iPLATO for a range of reasons:

  • iPLATO Patient Care Messaging freed up 300,000 urgent GP appointments in 2014. With a larger user base this number will increase significantly in 2015 allowing more patients to be seen in primary care and reducing the burden on local A&E. No other Health Tech provider brings benefits of this scale to the health service.
  • iPLATO Patient Care Messaging is independent of NHSmail SMS. Centrally funded text messaging on the internal NHS e-mail system is being abolished in 2015. CCGs and GP practices are seeking an experienced partner to continue popular text messaging services.
  • iPLATO is the only organisation in the UK which has successfully launched text messaging services across more than 50 PCT/CCGs. Through a tested change process the iPLATO team is able to bring the diverse population that work in GP practices to adopt new ways of communicating with patients.

Commenting, Tobias Alpsten, Chief Executive Officer of iPLATO said: "We have seen an accelerated uptake of the Patient Care Messaging service so far in 2015. While this growth is set to increase further in England in Q2 and Q3 due to the abolition of NHSmail SMS we are also seeing growing interest from Wales, Scotland and Northern Ireland. In times of rapid change it is reasonable that NHS organisations seek to partner with the most experienced organisation which offers the broadest and best product portfolio. For mobile communication in British primary care, this organisation happens to be iPLATO."

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mHealth and Analytics since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

Artificial Intelligence Detects a New Cl…

Many mutations in DNA that contribute to disease are not in actual genes but instead lie in the 99% of the genome once considered "junk." Even though scientists have recently...

Essen University Medicine and Siemens He…

The Essen University Medicine, Germany's leading hospital company for digitalized medicine, and Siemens Healthineers, a world-leading medical technology company, plan to work together to develop the hospital of the future...

Final Cohort Selected For Pioneering Dig…

Propel@YH has announced the six start-ups to participate in its inaugural digital health accelerator programme, aimed at navigating the complex healthcare landscape and building an NHS-relevant business case. The Leeds-based...

New Kid on the Block: The Doctrina Acade…

The Doctrina Academy is a new service, developed by Doctrina, a video e-learning platform that reaches over 1,000,000 healthcare professionals (HCPs) from around the globe, helping them to switch ...

Efficacy and SilverCloud Health Supports…

A leading mental health service is using the digital mental health platform developed by SilverCloud Health to support a confidential NHS service for GPs in England. London-based Efficacy is offering...

Gloucestershire Hospitals to Deliver EPR…

Gloucestershire Hospitals NHS Foundation Trust is moving to a 'clinical wrap' strategy to deliver an electronic patient record (EPR) and achieve the highest levels of digital maturity within five-years. The...

Mobile Phone App Designed to Boost Physi…

Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone...

Application Period for an International …

The Master of Science (M.Sc.)in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

NHS Prescribing is Back in the Spotlight…

Opinion Article by Dr Simon Hendricks, Product Innovation Manager and Clinical Strategy Lead, FDB (First Databank) Political will for better and safer prescribing in the NHS has fast gained momentum in...

Sectra to Provide Large Centralized Regi…

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional...

IMI to Boost Patient Involvement in its …

The Innovative Medicines Initiative (IMI) is creating a 'pool' of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels. IMI...